| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.937285 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240620103038 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 240422e202405 onc o f000 0 eng d |
|---|
| 020 | |a9780660715179 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-362/2024E-PDF |
|---|
| 245 | 00|aGuidance on submitting pediatric development plans and pediatric studies. |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cMay 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (32 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Lignes directrices sur la présentation de plans de développement pédiatrique et d'études pédiatriques. |
|---|
| 500 | |a"Effective date: 2024-02-26." |
|---|
| 500 | |a"Pub.: 240083." |
|---|
| 650 | 0|aPediatrics|zCanada. |
|---|
| 650 | 0|aDrug approval|zCanada. |
|---|
| 650 | 0|aPharmaceutical policy|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLignes directrices sur la présentation de plans de développement pédiatrique et d'études pédiatriques.|w(CaOODSP)9.937286 |
|---|
| 856 | 40|qPDF|s696 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H164-362-2024-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/pediatrics/guidance-submitting-development-plans-studies.html |
|---|